<SEC-DOCUMENT>0001144204-14-045715.txt : 20140730
<SEC-HEADER>0001144204-14-045715.hdr.sgml : 20140730
<ACCEPTANCE-DATETIME>20140730133100
ACCESSION NUMBER:		0001144204-14-045715
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20140730
FILED AS OF DATE:		20140730
DATE AS OF CHANGE:		20140730

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Dehaier Medical Systems Ltd
		CENTRAL INDEX KEY:			0001474627
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34661
		FILM NUMBER:		141002194

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 501, JIUZHOU PLAZA
		STREET 2:		83 FUXING ROAD,
		CITY:			HAIDIAN DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100856
		BUSINESS PHONE:		(8610) 5166-0080

	MAIL ADDRESS:	
		STREET 1:		SUITE 501, JIUZHOU PLAZA
		STREET 2:		83 FUXING ROAD,
		CITY:			HAIDIAN DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100856
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>v385167_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>U.S. SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WASHINGTON, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>For the month of July 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Commission File Number: 001-34661</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Dehaier Medical Systems Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Dehaier Medical Systems Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Room 501, 83 Fuxing Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Haidian District, Beijing 100856</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">People&rsquo;s Republic of China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Address of principal executive offices)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Form 20-F&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">x</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Explanatory Note:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Dehaier Medical Systems Ltd. (&ldquo;Registrant&rdquo;
or the &ldquo;Company&rdquo;) <FONT STYLE="font-family: Times New Roman, Times, Serif">held its 2014 Annual Meeting of Shareholders
on July 28, 2014, at 9:00 p.m., Eastern Time at its executive offices at Suite 501, Jiuzhou Plaza, 83 Fuxing Road, Haidian District,
Beijing, 100856, People&rsquo;s Republic of China. A total of 3,694,277 of the Registrant&rsquo;s ordinary shares were present
in person or by proxy, representing a quorum of 65.77%. The following tables reflect the certified tabulation of the votes with
respect to each proposal submitted to a vote of the Registrant&rsquo;s shareholders at the 2014 Annual Meeting of Shareholders.
Abstentions were counted as present for the purpose of establishing a quorum, but were not treated as votes cast on each respective
proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>1.</td>
    <td colspan="2">PROPOSAL 1: Election of Directors</td></tr>
<tr style="vertical-align: top">
    <td colspan="2">&nbsp;</td>
    <td>a.</td>
    <td>To elect two Class I member of the Board of Directors to serve a term expiring at the Annual Meeting of Shareholders in 2017 or until its successor is duly elected and qualified. Mr. Mingwei Zhang and Dr. Genhui Chen each received a plurality of the properly cast votes and was thereby elected to the Registrant&rsquo;s Board of Directors. The tabulation of the certified voting results is as follows:</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr>
    <td rowspan="2" style="vertical-align: bottom; text-decoration: underline; text-align: center"><b><u>Nominee</u></b></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><b>For</b></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td colspan="2" style="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><b>Withheld</b></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><b>Abstain/Broker Non-Vote</b></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td style="vertical-align: bottom; text-decoration: underline; text-align: center"><b><u>Number</u></b></td>
    <td style="vertical-align: top; text-decoration: underline; text-align: center"><b><u>Percentage</u></b></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td style="vertical-align: bottom; text-decoration: underline; text-align: center"><b><u>Number</u></b></td>
    <td style="vertical-align: top; text-decoration: underline; text-align: center"><b><u>Percentage</u></b></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td style="vertical-align: bottom; text-decoration: underline; text-align: center"><b><u>Number</u></b></td>
    <td style="vertical-align: top; text-decoration: underline; text-align: center"><b><u>Percentage</u></b></td></tr>
<TR STYLE="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; width: 21%">Mingwei Zhang</td>
    <td style="vertical-align: top; width: 1%; text-align: center">&nbsp;</td>
    <td style="vertical-align: top; width: 11%; text-align: center">1,730,133</td>
    <td style="vertical-align: top; width: 13%; text-align: center">98.52</td>
    <td style="vertical-align: top; width: 1%; text-align: center">&nbsp;</td>
    <td style="vertical-align: top; width: 9%; text-align: center">26,050</td>
    <td style="vertical-align: top; width: 13%; text-align: center">1.48</td>
    <td style="vertical-align: top; width: 1%; text-align: center">&nbsp;</td>
    <td style="vertical-align: top; width: 15%; text-align: center">1,938,094</td>
    <td style="vertical-align: top; width: 15%; text-align: center">N/A</td></tr>
<TR STYLE="background-color: White">
    <td style="vertical-align: bottom">Genhui Chen</td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td style="vertical-align: top; text-align: center">1,730,087</td>
    <td style="vertical-align: top; text-align: center">98.51</td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td style="vertical-align: top; text-align: center">26,096</td>
    <td style="vertical-align: top; text-align: center">1.49</td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td style="vertical-align: top; text-align: center">1,938,094</td>
    <td style="vertical-align: top; text-align: center">N/A</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>2.</td>
    <td colspan="2">PROPOSAL 2: Ratification of Appointment of Independent Auditor</td></tr>
<tr style="vertical-align: top">
    <td colspan="2">&nbsp;</td>
    <td>a.</td>
    <td>To ratify the appointment of Friedman LLP as the Registrant&rsquo;s independent registered public accountant for the fiscal year ending December 31, 2014. The proposal was approved by a majority vote of 98.91% of the votes cast. The tabulation of the certified voting results is as follows:</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><b>For</b></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td colspan="2" style="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><b>Withheld</b></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><b>Abstain/Broker Non-Vote</b></td></tr>
<tr>
    <td style="vertical-align: top; width: 1%; text-align: center">&nbsp;</td>
    <td style="vertical-align: bottom; width: 13%; text-decoration: underline; text-align: center"><b><u>Number</u></b></td>
    <td style="vertical-align: top; width: 16%; text-decoration: underline; text-align: center"><b><u>Percentage</u></b></td>
    <td style="vertical-align: top; width: 1%; text-align: center">&nbsp;</td>
    <td style="vertical-align: bottom; width: 12%; text-decoration: underline; text-align: center"><b><u>Number</u></b></td>
    <td style="vertical-align: top; width: 16%; text-decoration: underline; text-align: center"><b><u>Percentage</u></b></td>
    <td style="vertical-align: top; width: 1%; text-align: center"><b>&nbsp;&nbsp;</b></td>
    <td style="vertical-align: bottom; width: 16%; text-decoration: underline; text-align: center"><b><u>Number</u></b></td>
    <td style="vertical-align: top; width: 24%; text-decoration: underline; text-align: center"><b><u>Percentage</u></b></td></tr>
<TR STYLE="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td style="vertical-align: bottom; text-align: center">3,648,239</td>
    <td style="vertical-align: top; text-align: center">98.76</td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td style="vertical-align: top; text-align: center">40,354</td>
    <td style="vertical-align: top; text-align: center">1.09</td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td style="vertical-align: bottom; text-align: center">5,684</td>
    <td style="vertical-align: bottom; text-align: center">0.15</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>3.</td>
    <td colspan="2">PROPOSAL 3: Approval of the Company&rsquo;s 2014 Share Incentive Plan</td></tr>
<tr style="vertical-align: top">
    <td colspan="2">&nbsp;</td>
    <td>a.</td>
    <td>To vote to approve the Dehaier Medical Systems Limited 2014 Share Incentive Plan (the &ldquo;2014 Plan&rdquo;), which was previously approved by the Company&rsquo;s Board of Directors on June 26, 2014, subject to approval by the shareholders of the Company. The tabulation of the certified voting results is as follows:</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><b>For</b></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td colspan="2" style="vertical-align: top; border-bottom: black 1pt solid; text-align: center"><b>Withheld</b></td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><b>Abstain/Broker Non-Vote</b></td></tr>
<tr>
    <td style="vertical-align: top; width: 1%; text-align: center">&nbsp;</td>
    <td style="vertical-align: bottom; width: 13%; text-decoration: underline; text-align: center"><b><u>Number</u></b></td>
    <td style="vertical-align: top; width: 16%; text-decoration: underline; text-align: center"><b><u>Percentage</u></b></td>
    <td style="vertical-align: top; width: 1%; text-align: center">&nbsp;</td>
    <td style="vertical-align: bottom; width: 12%; text-decoration: underline; text-align: center"><b><u>Number</u></b></td>
    <td style="vertical-align: top; width: 16%; text-decoration: underline; text-align: center"><b><u>Percentage</u></b></td>
    <td style="vertical-align: top; width: 1%; text-align: center"><b>&nbsp;&nbsp;</b></td>
    <td style="vertical-align: bottom; width: 16%; text-decoration: underline; text-align: center"><b><u>Number</u></b></td>
    <td style="vertical-align: top; width: 24%; text-decoration: underline; text-align: center"><b><u>Percentage</u></b></td></tr>
<TR STYLE="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td style="vertical-align: bottom; text-align: center">1,633,535</td>
    <td style="vertical-align: top; text-align: center">96.99</td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td style="vertical-align: top; text-align: center">50,614</td>
    <td style="vertical-align: top; text-align: center">3.01</td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td>
    <td style="vertical-align: bottom; text-align: center">2,010,128</td>
    <td style="vertical-align: bottom; text-align: center">N/A</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Other Events.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
July 30, 2014, the Company issued a press release announcing the results of its 2014 Annual Meeting of Shareholders held on July
28, 2014. A copy of the press release is attached as Exhibit&nbsp;99.1 hereto and incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td>99.1</td>
    <td>Press Release dated July 30, 2014.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48pt">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48pt">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><b>DEHAIER MEDICAL SYSTEMS LIMITED</b></td></tr>
<tr style="vertical-align: top">
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td>
    <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td>
    <td style="width: 62%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">July 30, 2014</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">By:</td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">/s/ Ping Chen</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Ping Chen</b></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Chief Executive Officer</b></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>(Principal Executive Officer) and</b></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Duly Authorized Officer</b></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48pt">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v385167_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<DIV STYLE="border: Black 1pt solid">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left"><B><IMG SRC="image_002.jpg" ALT="" STYLE="height: 80px; width: 226px">&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Dehaier
Announces the Results of 2014 Shareholder Annual Meeting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 99%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 91%; text-align: justify; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>BEIJING, July 30, 2014 - Dehaier Medical Systems Ltd.</B> (NASDAQ: DHRM) (&ldquo;Dehaier&rdquo; or the &ldquo;Company&rdquo;), an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced the results of its 2014 annual general meeting of shareholders. </FONT></TD>
    <TD STYLE="width: 4%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The shareholders of Dehaier have approved all the matters submitted to them at the Company&rsquo;s 2014 annual general meeting held on 9:00 p.m., Eastern Standard Time, on Monday, July 28, 2014. A total of 3,694,277 shares were represented in person or by proxy at the Company's 2014 annual general meeting, representing a quorum of approximately 65.77% of the Company's outstanding shares. During the meeting, the following resolutions were duly passed: </FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 99%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify; text-indent: 0in"><font style="font: 10pt Times New Roman, Times, Serif">(i)</font></td>
    <TD STYLE="width: 86%; text-align: justify; text-indent: 0in"><font style="font: 10pt Times New Roman, Times, Serif">Election of two Class I members of the Board of Directors, to serve a term expiring at the Annual Meeting of Shareholders in 2017 or until their successors are duly elected and qualified;</font></td>
    <TD STYLE="width: 4%">&nbsp;</TD></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in"><font style="font: 10pt Times New Roman, Times, Serif">(ii)</font></td>
    <TD STYLE="text-align: justify; text-indent: 0in"><font style="font: 10pt Times New Roman, Times, Serif">Ratification of the appointment of Friedman LLP as the Company&rsquo;s independent registered public accounting firm for the fiscal year ending December 31, 2014;</font></td>
    <TD>&nbsp;</TD></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in"><font style="font: 10pt Times New Roman, Times, Serif">(iii)</font></td>
    <TD STYLE="text-align: justify; text-indent: 0in"><font style="font: 10pt Times New Roman, Times, Serif">Approval of the Company&rsquo;s 2014 Share Incentive Plan; and</font></td>
    <TD>&nbsp;</TD></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in"><font style="font: 10pt Times New Roman, Times, Serif">(iv)</font></td>
    <TD STYLE="text-align: justify; text-indent: 0in"><font style="font: 10pt Times New Roman, Times, Serif">Transaction of any other business properly coming before the meeting.</font></td>
    <TD>&nbsp;</TD></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 99%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 91%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr. Ping Chen, Dehaier&rsquo;s CEO and Chairman stated, &ldquo;On behalf of management, I would like to thank shareholders for their support and confidence in Dehaier. We will continue to focus on enhancing shareholder value as deploying our strategic planning of sleep respiratory business to further diversifying our growth strategies in the future. &rdquo;</FONT></TD>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dehaier&rsquo;s 2014 Shareholder Annual Meeting will be available online for a limited time at: http://www.media-server.com/m/p/ypjotr75 .</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 99%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 91%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>About Dehaier Medical Systems Ltd.</B></FONT></TD>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including medical devices and sleep respiratory products. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), HEYER (Germany) and Timesco (UK). Dehaier's technology is based on six patents and eleven software copyrights. More information can be found at http://www.dehaier.com.cn</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Forward-looking Statements</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dehaier Medical Systems Limited</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">+86 10-5166-0080</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Janice Wang wangxq@dehaier.com.cn</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`!0`.(#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MHH`**KSW"PCNSG.U1U)QD#ZG!Q3X9DGA26-MR,`RD=P:+:"NMB6BBB@84444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!12"HI
MIO)4,(V?/92`?U(H!DM5+V8P6S2]%'WFZ[1TW8]!U/MFL+5_$]Q9`K%#:QN>
MAN;D$GZ)&&8_ABN7O_$^OL/FNGCB8'(CTK8O_?4[C/Y5M3H2D93JQB;VH:B4
MRSEE;)W!>64K\S!1W93\X'\2D@5!I7B86FH;+@H+.:15D*-E897Y1U/>*7J#
MV;(/7CA[;6?/=K.XFD>6)`5=98S++$O(8",D"6(Y93_$H*G-->Y"LT<D<<RA
M64QQ<+,C#<Z+Z*ZXEC_NL&`]*ZOJ[UC8YO;:W1[G17"^%_%HETYM/GG6XO[8
M`1RN<">`C*S$]AM^\>Q!'4UTEIJ8;:LI.3C!Q@\\C([$]0HR0.3BN*5.479G
M7&HI*YKT9IH97&5((]0<UYYJOQ.6U\?1>%;#3TN9"RI).\XC56(R0,CG`]^3
MQ4%K4]%HKRW7_C`NB6BROH,XDD;:@>ZB(..3G8S$<>V*LZ5\56OM.@N9O#]R
MK2C<!%<PD%2>"-S`Y([$"E<=CTFBN)\:>/D\&6]C/+ICW4=UP56=5D0\$94Y
M)')Y'`(QW%5=:^)2V2Z9_8^B7NK/?1B8"-2@C#<`,2"`V<Y'&,>],+,]`HKB
M7\>3VL<1O/#&IV[R$*`TL`!;&<`F09K<.OP6_AQ];U&&6Q@CC:1XYBI90"<?
M=)!)XP`><B@+,VJ*\L\-?%VX\0SS.OA?4FLHN#+:(9R&XP"``!QD]:W+[XE:
M?I=HUW?Z+KUK;J0&EFL2J@DX`R3C.:5PLSMZ*YSPSXPT_P`6Z?/?Z9%="WB<
MH7FCVAB!DA>3G&1^=<OIGQALM9:Y&GZ'J,PMD,DS;XE$:YQDEF``IA9GI=%<
M):_$9KZ$R6GAV]GC4[2T=U;D`^F1)UK8T7Q+<:O>-`^AWMG&%)\Z22)E![`[
M6)!/...U`69T=%<SJWCC0M)BU-I;EII=,56NH(4)=`Q`'7`/)'>L)?BG'?Z;
M]LT7POXAU%6.(REH1&V#@_."1Q@]CSQ0%F>ATE<1!\0Y&MT>X\'^*(IBN71-
M/+!3Z`Y&1[X%=A;S"YMH9@DD?F('V2+M9<C.".Q'0CL:!6+%%%%`!1110`55
MO$#6S;MI`&?F`(_4$?I5JFL`RD'.#P<4+035T<-JB2-$R02/@@DK;^8V?JL2
MK^K`5PFHQV5M(?M#00R=3YKVT3?B#YLGYG-=SX^BMX[6QMRTF)IS)-F1N(8E
M,C\9Q@X`/UKRLZ9&C*[0*'AC,CHJCE@OF,./]N2-1[#%>KA$FKWL<%=M2L17
M5RD\JMILJR7<#"2,P/+(RD'@X$:K_2F7FKC[.K1JT,HY6,`AHSNR4`/(*2?,
MO^RQ%;W@C7;;PIXEU"&2Q>XC*K"TT/,B[!\Q"_Q*6R3CD8%9=_KEAK'BZ]UN
M&!K5F8",$;FC(`&\*>#*<<#H#R3Q78F_:-<NB6YSM+EO?Y&YH:-IT&Z1(_M+
MO^\C8X16!+K`#V1"3+)V&`O7(KK=.U/?U,CDA3SQ(^_[H]I)3EC_`'4`'';B
M+24W&S;'%L"E4A=\Q[5.Y@S?\\E/S2.>78!1P*]!\%Z4URT>KW!=H5+-:F5<
M/,[??N&'8L.%'\*@#O7!B4E=LZ:-W9(Z^R@>"$>:P:0XR%X5?15'8#IZGO7A
M7BDS6/Q\@V2B=Y_+4><H(C#J5(4`<8!.#R03GDU]!5XSXX\`^*]:^)::UHHB
MMX46(1W;RJ-C*.3MY)P?:O,9WQT/.M/MK33-(CM;N/2II$U&.Z:XD:12T:@@
MPG,?0GGKCV-3W=M9:K;_`&:VBTFT,VJ-=+<H9&VQ,`!$,1C*@\YSCV%=*O@C
MQGHM[J&G7]I<^(=(O[?RY&AN0"&R&5UWD[65AW&""?6H_#GA_P`<:1XCL[BX
MT75KG3+0[;:S>_554`G:&(X(!))XY^G%*Q=S;^/4GV?P_H42I&7\YL3;?F7:
MH^Z>H![CO@>E<-XUO+B\\9:(EU%?RJ;*U65';#W0YRRX/(;)`/!)]*]1^+OA
M+6_%EAH\&E6BRR12NTN9558P5`Y)(SR#T%5]<^%&I:UK6CZI%K$5E+8VEO$0
M(BY#Q\E@<@'D\9':FT)-'C&JP6;Z%+>P039^VB)9!$5CC&UB4)+$ENF..@/-
M?0'@Z+3=3^$VF)K-F/L,%J&E6Z7"D(,[QSRO<&N"\8_#SQ%=W`TK38KF\$ER
M)I9VMH((&)4_,64Y)&2""!WQGBN[U7P)JM_X!TWPQ;:XEG%!;K#=,(-PG``P
M!R"!D'ZCK18&T>0WOB;5M;TSQ%;Z`D.F>&+11*;>&(+\I=57)'.YB`3SV(Z"
MLVUU;7=-\'6-U.(=0T.6_;=;W,>]1*H4D$GD94\8/KBO5-8\"3^&?AG<^'-$
ML+C5+O47!GN8]JX8,I!()R%P"`!G!R3UJ_X6^&KI\,9O#>O[%DN9FG_=')A8
MXVD'H2,=N,$BE8=U8ZWPO/I%UX1MKG0H(K?3YHBZ11@`(3G<"!W!R#]*\(^%
M&G1ZI/XAM9=,&IJT$9^R&?RA)B0=6[8ZX/7%>M>`_`NI^"X;RS;6Q>Z?+N:.
MW\C85<X&X')QD#D#C/-<'X#\'>._"UYJDL.CQ(]U!Y2R27:*8SDD%<!@2/0C
M%-B5CDO'0L5\9:?I]OHEEI0LT2.>W%RKH3N+?.X&`<$`YR1WKWSPH67S##X7
ML])LYD$BSVL\3K*>W"`9X)(//ZUP>C>`M8TI-2\_PS:ZC-J*E+B:[U0%BI.2
M`0@P2<'/7('I73>`=$\0>'&;3KBT$6EG+H)+[SS">?E0!!P2<G)XQ[T(&]#B
MOB'IDVDZCXPN1=:?*NJ6L3"`7&VXB"LI)\O!R"0><CUK;^&_AJVU_P"&FC/<
M7FI6YA:<#['=M"&!E8\A3@XQQ]36;XV\+:R=6\0W9L+S4[W5K=(;1[.`>3;Q
MAER&8MD-A1T&.2<\\=QX#TN]\(_#NSM-2MI&N8M[R0VZ^:PW.2``.I`(SC/>
MCJ%]#SKP)!J7BSQM=7-AK.JV>B:9*I,,UZ\LDIR<`Y.,':2>P'`]:]YQ7EGP
M>\+ZQH"ZU<:K9M:+>2(85D(W$`MDD`\=1UYKU2F2V%%%%`!1110`4444`<#X
MUMWO]96#;E!:+!_W_G16_P#'48?C7*+;B28W#C"R2+,>.,%Y;@_^.QQCZ8KT
M?4+=I;V6?:2=Z[>.HC!*_F[X_"LJ71HS`8$48*F,<9R"BP#\QO(]LUVT:W+&
MQRSIMR;/(-*M)SG>ADDDS,T+H2PR<[@H(8CGAXR2.XS6PVG6.J1>;=HK@':)
MVDVLIY&!<*"I/^S*H(Z9KT'4?AS`(B-(D1(P=WV*Z!>'=ZHP.^(^ZG\*PGTN
MZL+D&]MY[:48`FG+$$<\"ZB&2/02J?>NKZU&>VYA["4=T5M'\)QI=P&YFDEL
M&8%[>5`C3!<;$$@)C=`>=JD9/4$UZW;R))"&0$*.,%<$8[$'I7):9:B*-=@V
M^;W`3$GXK\DGT(5O?-==!$(H40#&`.!G`]AGFO/KS<W=LZJ4%%:(GS7FOBSQ
M3KEKXDUFTTZ]CM;72M(-\Y,`D+R9^523T!'IZ5Z5BN<U'P3H.K7]Q>WEF\DU
MPJ)/B9U655^Z&4$`@8Z$5@;HR+KQY)I6A^&Y;RS274=8C4A1(8XT.T%F)P2`
M,CH#UIEWXZN)?AOJ?B.*Q>QNK</'''-\PWA@H/(&021U`KH]2\,Z3JQLFN;;
M$ECG[-)$[1M%D`$*5((&`!CV%)/X7TBYT/\`L::U,EB6#M&TC$LP8-DMG))(
MR<FEJ.Z,GP[XNN;^]N]*U.R\B]L+2*XFE2561]ZY]`%/?!X]ZJZ1\1(]3\26
M&CK9Q'[9%)*DUO="8(%!)#?*!V(R"1GN:Z1/#VEQW>HW(LT,NHQK'=%B2)%5
M2H!!.`,''&*IZ7X*T'1;^&]L+(I/!$8HF:9V\M"<E5!)`'7@#O1J!C6WCCR;
M3Q9JETLLMEH]T8(T55!8KP0",=21R>E6O#'C=_$.HRVDVEO:*MJMR)A(73!Q
ME22JX89YQD>]:D7A31(]*O\`3%L5-G?RM-<QL['S'8C)))SU`[]JFL/#NG:=
M%+'!'+B6,1,99WD.P9`4%B2`,G@8HU#0P_"7C+4/%8BNH_#[V^F.9!]K>Z4Y
M*G``7`)R<\\8QWKK+NX6TLI[AONQ1M(<^@!/]*K:/I-CH>FPZ;IT`@M(01&@
M8G&22>22>I)JQ>6D-]93VEPI>*:-HY%R1E6&",CD<$]*8CQ;3?BMXB_X1_4?
MM\,1U>6%;C3L1`*8B&+N<<$*%)Y[X%=7;_$*>Q\->&9-1MUN=4UA&?`;RD4#
MDL2`2!@C@`YYKK_^$;TD:%_8GV118"`VX0,0?+(P5W9SW/>J]SX0T6Z33U:U
M=&TY?+M'AF:-XEQ@@,I!P0,<FE9CNC$3XA^;HVDW*Z-.M]J=X;."TDD"X8'E
MBQ&0H'.<9YZ5CQ^/=5'@_P`2ZS=!4>UU$V=FD*JQ7YE7J1AN2>2.U=I<^$-$
MN[*TM)K,F.SD\RW<2L'1B<E@X.[)/4YYJ,>"?#ZZ(-'%@?L/VC[3Y7FL<R9S
MDG.3SV)Q1J%T5]1\4W-EJVG:):::U_J5S:&Z<-,(555X))P>2<@#`'N*9XB\
M9C0%B5[:W\YK5KEHIKP(P`ZJ`H8D]><!>.M:6J>%='UJ^AO+ZUWW$49B$B2,
MA*$Y*G:1E2<\'(Y-1ZKX-T/6KI;F]LB9A`;;?'*T9,1_@.TC(Y/!HU#0P)O&
MMW?'P:^GP^0-;F+2QRC<RQ*I)`(_//I7?US=QX)T*[CTU'M9(_[-C,5H89W0
MQ*0`0"I!YP/>MRWB2WMXX4+;8U"C<Q8X`QR3R?J>M`F6****8!1110`4444`
M(0#U%,\J,$'8,C&#CTSC^9_.I**+@%)@$8-+10!333X(Y3)&GED\LJ@!6],C
MH2/7K[U<HHHN^HD%%%%`PHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
-**`"BBB@`HHHH`__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
